Abstract

The exposure to respirable crystalline silica (RCS), e.g. quartz, in industrial settings can induce silicosis and may cause tumours in chronic periods. Consequently, RCS in the form of quartz and cristobalite has been classified as human lung carcinogen category 1 by the International Agency for Research on Cancer in 1997, acknowledging differences in hazardous potential depending on source as well as chemical, thermal, and mechanical history. The physico-chemical determinants of quartz toxicity are well understood and are linked to density and abundance of surface silanol groups/radicals. Hence, poly-2-vinylpyridine-N-oxide and aluminium lactate, which effectively block highly reactive silanol groups at the quartz surface, have formerly been introduced as therapeutic approaches in the occupational field. In the traditional ceramics industry, quartz-containing raw materials are indispensable for the manufacturing process, and workers are potentially at risk of developing quartz-related lung diseases. Therefore, in the present study, two organosilanes, i.e. Dynasylan® PTMO and Dynasylan® SIVO 160, were tested as preventive, covalent quartz-coating agents to render ceramics production safer without loss in product quality. Coating effectiveness and coating stability (up to 1 week) in artificial alveolar and lysosomal fluids were first analysed in vitro, using the industrially relevant quartz Q1 as RCS model, quartz DQ12 as a positive control, primary rat alveolar macrophages as cellular model system (75 µg cm−2; 4 h of incubation ± aluminium lactate to verify quartz-related effects), and lactate dehydrogenase release and DNA strand break induction (alkaline comet assay) as biological endpoints. In vitro results with coated quartz were confirmed in a 90-day intratracheal instillation study in rats with inflammatory parameters as most relevant readouts. The results of the present study indicate that in particular Dynasylan® SIVO 160 (0.2% w/w of quartz) was able to effectively and stably block toxicity of biologically active quartz species without interfering with technical process quality of certain ceramic products. In conclusion, covalent organosilane coatings of quartz might represent a promising strategy to increase workers’ safety in the traditional ceramics industry.

Highlights

  • Prolonged exposure to respirable crystalline silica (RCS) can induce silicosis and may cause lung tumours in chronic periods

  • RCS in the form of quartz and cristobalite has been classified as human lung carcinogen category 1 by the International Agency for Research on Cancer in 1997, acknowledging differences in hazardous potential depending on source as well as chemical, thermal, and mechanical history

  • The results of the present study indicate that in particular Dynasylan® SIVO 160 (0.2% w/w of quartz) was able to effectively and stably block toxicity of biologically active quartz species without interfering with technical process quality of certain ceramic products

Read more

Summary

Introduction

Prolonged exposure to respirable crystalline silica (RCS) can induce silicosis and may cause lung tumours in chronic periods. By using as-grown quartz crystals with intact surfaces, Turci et al (2016) recently demonstrated that the biological activity of quartz thereby seems not be determined by silanol groups per se but that it needs conchoidal surface fractures and a disordered panel of silanols, siloxanes, and rings for quartz–cell membrane interactions It should in any case be possible to neutralize these active centres and to reduce silanol heterogeneity by strong adsorption of certain molecules such as aluminium salts, metal iron, proteins, or phospholipids to prevent deleterious quartz–cell membrane interactions, which can result in formation of reactive oxygen species, membrane damage/haemolysis, cytotoxicity, DNA damage, cytokine release, and subsequently lung toxicity, inflammation, silicosis, and even tumour formation (Fubini, 1998a, 1998b; Schins et al, 2002; Albrecht et al, 2004). Clear correlation between quartz-mediated haemolytic activity and inflammasome activation could be demonstrated by Pavan et al (2014), pointing to the same physico-chemical structures as determinants

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call